Longevity Health Holdings Inc (XAGE) is a bio-aesthetics company focused on longevity and healthy aging that develops and sells cosmetic skincare and haircare products. Revenue is generated through three channels: business-to-business sales, direct-to-consumer sales, and distributor sales, all primarily in the United States. The company's core product line, branded Carmell Secretome, uses allogeneic platelet-rich plasma sourced from FDA-registered, AABB-accredited blood banks, formulated via a proprietary microemulsion technology that avoids 14 excipients the company calls the Foul Fourteen. As of December 31, 2025, the company carried negative net working capital and consumed $3.3M in operating cash during FY2025, with its auditors preparing financial statements under a going concern assumption. CEO and Chairman is Janakiram Ajjarapu, with Bryan J. Cassaday serving as CFO, as of the 10-K filed March 31, 2026. The company was formerly known as Carmell Regen Med Corporation and adopted its current identity following a transaction that closed July 14, 2023.

Revenue model

Transactional product sales across three channels: business-to-business, direct-to-consumer, and distributor, primarily in the United States (FY2025, per 10-K filed 2026-03-31).

Products and services

Carmell Secretome branded cosmetic skincare and haircare products using allogeneic platelet-rich plasma and a proprietary microemulsion formulation. Products are designed to be non-comedogenic and free from mineral and vegetable oils. A regenerative bone and tissue healing product pipeline exists but further research and development has been paused (per 10-K filed 2026-03-31).

Customers and end markets

Professional care providers (business-to-business channel) and retail consumers (direct-to-consumer channel), with distributor sales as a third channel. End market is cosmetic skincare and haircare in the United States (per 10-K filed 2026-03-31).

Value-chain role

Developer and marketer of finished cosmetic products. Manufactures Carmell Secretome using PRP sourced from third-party FDA-registered, AABB-accredited blood banks. Sells through its own direct and distributor channels.

Geographic exposure

Primarily United States (per 10-K filed 2026-03-31).

Source: SEC 10-K, filed 2026-03-31

Industry: Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics Peers: Spyre Therapeutics Inc Rezolute Inc Connect Biopharma Holdings Ltd Vistagen Therapeutics Inc Lantern Pharma Inc Dianthus Therapeutics Inc NextCure Inc Molecular Templates, Inc.